Becker's Healthcare March 19, 2025
Purdue Pharma has submitted a revised Chapter 11 bankruptcy plan proposing more than $7.4 billion in cash payments to creditors, including U.S. states and others, to compensate victims of the opioid crisis, Bloomberg reported March 18.
The plan includes the dissolution of Purdue and the creation of a new public benefit company, which will operate independently of the company’s current owners, the Sackler family.
Under the proposal, the Sacklers would contribute up to...